Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients
Nur Atik,1,2 Rira Uji Hayati,3 Laniyati Hamijoyo2,4 1Department of Biomedical Sciences, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia; 2Lupus Study Centre, Immunology Study Group, Padjadjaran University/Hasan Sadikin Hospital, Bandung, West Java, Indonesia; 3Faculty of M...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1c06907b78894eee91fd4aadab6e11da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1c06907b78894eee91fd4aadab6e11da |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1c06907b78894eee91fd4aadab6e11da2021-12-02T05:47:44ZCorrelation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients1179-156Xhttps://doaj.org/article/1c06907b78894eee91fd4aadab6e11da2020-03-01T00:00:00Zhttps://www.dovepress.com/correlation-between-steroid-therapy-and-lipid-profile-in-systemic-lupu-peer-reviewed-article-OARRRhttps://doaj.org/toc/1179-156XNur Atik,1,2 Rira Uji Hayati,3 Laniyati Hamijoyo2,4 1Department of Biomedical Sciences, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia; 2Lupus Study Centre, Immunology Study Group, Padjadjaran University/Hasan Sadikin Hospital, Bandung, West Java, Indonesia; 3Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia; 4Department of Internal Medicine, Padjadjaran University/Hasan Sadikin Hospital, Bandung, West Java, IndonesiaCorrespondence: Laniyati HamijoyoDepartment of Internal Medicine, Padjadjaran University/Hasan Sadikin Hospital, Jl. Pasteur 38, Bandung 40161, West Java, IndonesiaTel +62 222034953Fax +62 22 2032216Email hamijoyo@yahoo.comPurpose: Systemic lupus erythematosus (SLE) is an autoimmune disease with high mortality and morbidity rates, one of the causes of which is cardiovascular events. Dyslipidaemia is known to be one of the main risk factors for cardiovascular disorders and can be induced by steroid therapy, which is commonly administered to SLE patients. This study aimed to determine whether there is a correlation between steroid dose and lipid profile in SLE patients.Methods: The study was a correlative analytic study with a cross-sectional design. Data were obtained from the Hasan Sadikin Lupus Registry (HSLR) and the medical records of patients registered in the Rheumatology Division, Dr Hasan Sadikin Hospital, Bandung, from 2008 to 2019. Inclusion criteria were SLE patients who had undergone lipid profile examination and received steroid therapy. We excluded patients taking cyclosporine A or statins, and patients treated with steroids for less than a year. A simple random sampling method was performed and Pearson’s correlation test was used for the analysis.Results: We recruited 41 female patients with an average age of 30.88 ± 9.29 years old. The average dose of steroid in this study was 5.63 mg/day, while the average lipid profile was 177.51 mg/dL, 105.22 mg/dL, 61 mg/dL and 92.98 mg/dL for total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglycerides, respectively. Correlations between steroid dose and total cholesterol (r = 0.375; p = 0.016), and between steroid dose and triglyceride level (r = 0.416; p = 0.007) were statistically significant in SLE patients. However, this study showed no correlation between steroid and HDL level (r = 0.206; p = 0.196) or LDL level (r = 0.308; p = 0.05).Conclusion: This study showed that the applied steroid dose in SLE patients correlated with total cholesterol and triglyceride levels, but not with HDL or LDL.Keywords: systemic lupus erythematosus, SLE, dyslipidaemia, steroid therapyAtik NHayati RUHamijoyo LDove Medical Pressarticlesystemic lupus erythematosus (sle)dyslipidaemiasteroid therapyDiseases of the musculoskeletal systemRC925-935ENOpen Access Rheumatology: Research and Reviews, Vol Volume 12, Pp 41-46 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
systemic lupus erythematosus (sle) dyslipidaemia steroid therapy Diseases of the musculoskeletal system RC925-935 |
spellingShingle |
systemic lupus erythematosus (sle) dyslipidaemia steroid therapy Diseases of the musculoskeletal system RC925-935 Atik N Hayati RU Hamijoyo L Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients |
description |
Nur Atik,1,2 Rira Uji Hayati,3 Laniyati Hamijoyo2,4 1Department of Biomedical Sciences, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia; 2Lupus Study Centre, Immunology Study Group, Padjadjaran University/Hasan Sadikin Hospital, Bandung, West Java, Indonesia; 3Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia; 4Department of Internal Medicine, Padjadjaran University/Hasan Sadikin Hospital, Bandung, West Java, IndonesiaCorrespondence: Laniyati HamijoyoDepartment of Internal Medicine, Padjadjaran University/Hasan Sadikin Hospital, Jl. Pasteur 38, Bandung 40161, West Java, IndonesiaTel +62 222034953Fax +62 22 2032216Email hamijoyo@yahoo.comPurpose: Systemic lupus erythematosus (SLE) is an autoimmune disease with high mortality and morbidity rates, one of the causes of which is cardiovascular events. Dyslipidaemia is known to be one of the main risk factors for cardiovascular disorders and can be induced by steroid therapy, which is commonly administered to SLE patients. This study aimed to determine whether there is a correlation between steroid dose and lipid profile in SLE patients.Methods: The study was a correlative analytic study with a cross-sectional design. Data were obtained from the Hasan Sadikin Lupus Registry (HSLR) and the medical records of patients registered in the Rheumatology Division, Dr Hasan Sadikin Hospital, Bandung, from 2008 to 2019. Inclusion criteria were SLE patients who had undergone lipid profile examination and received steroid therapy. We excluded patients taking cyclosporine A or statins, and patients treated with steroids for less than a year. A simple random sampling method was performed and Pearson’s correlation test was used for the analysis.Results: We recruited 41 female patients with an average age of 30.88 ± 9.29 years old. The average dose of steroid in this study was 5.63 mg/day, while the average lipid profile was 177.51 mg/dL, 105.22 mg/dL, 61 mg/dL and 92.98 mg/dL for total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglycerides, respectively. Correlations between steroid dose and total cholesterol (r = 0.375; p = 0.016), and between steroid dose and triglyceride level (r = 0.416; p = 0.007) were statistically significant in SLE patients. However, this study showed no correlation between steroid and HDL level (r = 0.206; p = 0.196) or LDL level (r = 0.308; p = 0.05).Conclusion: This study showed that the applied steroid dose in SLE patients correlated with total cholesterol and triglyceride levels, but not with HDL or LDL.Keywords: systemic lupus erythematosus, SLE, dyslipidaemia, steroid therapy |
format |
article |
author |
Atik N Hayati RU Hamijoyo L |
author_facet |
Atik N Hayati RU Hamijoyo L |
author_sort |
Atik N |
title |
Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients |
title_short |
Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients |
title_full |
Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients |
title_fullStr |
Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients |
title_full_unstemmed |
Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients |
title_sort |
correlation between steroid therapy and lipid profile in systemic lupus erythematosus patients |
publisher |
Dove Medical Press |
publishDate |
2020 |
url |
https://doaj.org/article/1c06907b78894eee91fd4aadab6e11da |
work_keys_str_mv |
AT atikn correlationbetweensteroidtherapyandlipidprofileinsystemiclupuserythematosuspatients AT hayatiru correlationbetweensteroidtherapyandlipidprofileinsystemiclupuserythematosuspatients AT hamijoyol correlationbetweensteroidtherapyandlipidprofileinsystemiclupuserythematosuspatients |
_version_ |
1718400218209189888 |